提示! 期刊投稿指南社区正式上线内测,尚有很多功能并未实现,如果您在测试过程中发现期刊信息有错误,请戳此反馈:期刊信息问题。网站功能问题,请加站长微信:620100690
  1. 首页
  2. 英文期刊ONCOLOGY

Translational Lung Cancer Research

TRANSL LUNG CANCER R

ISSN:2218-6751 E-ISSN:—  出版商:Society for Translational Medicine (STM)  国家:Hong Kong  周期:monthly

影响因子(2024)
3.500
中科院分区(2025 官方末版)
3 区
JCR 分区
Q1
审稿周期
In-house review: 1-3 weeksExternal peer review: 1-3 monthsPublic
录用比例
暂无
收录情况  h-index:0  CiteScore:4.30
投稿入口: 投稿系统  期刊官网 

期刊简介

Translational Lung Cancer Research(TLCR| Transl Lung Cancer Res| Print ISSN 2218-6751; Online ISSN 2226-4477) is an international| peer-reviewed| open-access journal| which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year| and published bimonthly since February 2013. It provides practical up-to-date information on prevention| early detection| diagnosis| and treatment of lung cancer. Specific areas of its interest include| but not limited to| multimodality therapy| markers| imaging| tumor biology| pathology| chemoprevention| and technical advances related to lung cancer.

投稿经验(0 条,)

数据整理自公开网络的投稿反馈,仅供参考。